The chicken chorioallantoic membrane (CAM) is a classical in vivo biological model in studies of angiogenesis. Combined with the right tumor system and experimental configuration this classical model can offer new approaches to investigating tumor processes. The increase in development of biotechnological devices for cancer diagnosis and treatment, calls for more sophisticated tumor models that can easily adapt to the technology, and provide a more accurate, stable and consistent platform for rapid quantitative and qualitative analysis. As we discuss a variety of applications of this novel in vivo tumor spheroid based shell-less CAM model in biomedical engineering research, we will show that it is extremely versatile and easily adaptable to an array of biomedical applications. The model is particularly useful in quantitative studies of the progression of avascular tumors into vascularized tumors in the CAM. Its environment is more stable, flat and has a large working area and wider field of view excellent for imaging and longitudinal studies. Finally, rapid data acquisition, screening and validation of biomedical devices and therapeutics are possible with the short experimental window.
INTRODUCTION
Effective investigations in cancer research, whether in cancer dynamics, drug delivery, drug and diagnostic tool development, involves the use biological models that closely reflect realistic solid tumors.
While in vitro models may not provide a complete assessment of the processes that occur only in the environment of solid tumors [1] , scientists have relied on tumor in vivo models or the integration of tumor in vitro models with in vivo models to circumvent the shortcomings in in vitro models.
Current integration approaches typically introduce tumor cells to in vivo models as single cell suspensions, multi-layered systems such as biopsies, or embedded in scaffolds such as gels or sponges prior to implantation [2, 3] . Additionally, some investigators add exogenous factors in the culture medium or scaffolds to induce certain functions such as angiogenesis [4] and invasion, that may manifest only in in vivo environments [5] .
Single cell suspensions and biopsies may not be ideal tumor systems for bioengineering applications requiring quantitative analysis. This is because, biopsies cut directly from the animal host may not have a homogeneous cell population, and single cell suspensions lack a uniform and constant shape.
In contrast, the symmetric 3D configuration of multi-layered tumor spheroids, a sphere, and the radial dependency of their proliferative and metabolic properties, can facilitate the generation of boundary conditions and fixed data points useful in quantitative investigations, such as computational modeling of tumor growth [5] . Tumor spheroids have been used extensively in studies of cancer dynamics both as an in vitro model [7, 8, 9, 10] and combination with an in vivo model [9] because they manifest similar growth and morphological dynamics of solid tumors. They begin with an avascular growth stage where the tumor grows to a certain size in vitro generating a necrotic center. As we demonstrate later in the article, tumor spheroids can induce angiogenesis and promote vascular growth when introduced to an in vivo environment with existing vascular network.
Biomedical imaging systems ideally require a wide working area, and a steady flat environment for consistent analysis. Imaging resolution and light penetration deep into animal tissue can be compromised due to excessive light scattering and absorption from animal tissues. Qualitative and quantitative data acquisition may be facilitated with tissue of greater transparency such as the chicken embryo chorioallantoic membrane (CAM).
The traditional in-shell CAM model [12] , although still useful as an alternative system to animal models for studies of tumor angiogenesis [13] and tumor dynamics [14, 15] , is not optimal for imaging and biomedical engineering investigations due to its restricted and unstable environment. Within the shell environment, the embryo can move freely in the presence of perturbations. Drug injections and imaging studies can be challenging with constant movement of the medium. In addition, the experimental window of the shell model can be very small, restricting access to the entire vessel network and limiting the size of the experimental site. Surface tension may cause the surface of the CAM in the shell model to curve.
The shell-less CAM version was introduced to address the drawbacks of the traditional shell CAM model [16, 17, 18] . The shell-less CAM model not only offers a stable and flat environment, it also offers a large experimental area and wider field of view useful for imaging and biomedical engineering applications.
Unlike current shell-less models, our model is the first model to use three-dimensional spheroids as the tumor system of choice. The three-dimensional spheroids are implanted directly into the CAM, and vascularized spheroids are generated endogenously without the use of growth factors to promote angiogenesis or scaffolds to secure and confine the tumor inside the CAM.
This form of vascularization allows the study of the tumorigenic behavior of three dimensional tumors without the application of exogenous signals that could otherwise interfere with the natural processes of tumors. Tumor spheroids combined with the shell-less CAM model can enhance the capabilities of bioengineering modalities by providing a sophisticated tumor model with excellent imaging properties that can facilitate the studies of the angiogenic switch, and model the onset of tumor progression quickly and more effectively.
MATERIALS AND METHODS
The in vivo shell-less CAM tumor spheroid model was prepared as follows:
Initially, monolayers of ACBT grade IV human glio blastoma were cultured in T-75 culture flasks containing enhanced Dulbecco modified Eagle medium (DMEM), supplemented with 10% heat-inactivated fetal bovine serum, 1% of streptomycin, penicillin, L-glutamine, and non-essential amino acids. The cells were maintained at 37°C and 8% CO 2 in a tissue culture incubator. After reaching 60% confluence, small tumor aggregates started to form. Using the liquid overlay method [7] , ACBT suspension aggregates were collected from the flasks and transferred to culture medium filled square Petridishes with the bottom covered with 2% agar. Culture medium was changed three times a week. The tumor spheroids derived from ACBT suspension aggregates grew to 1 mm in diameter in approximately 30 days. For consistency, 1 mm 3 spheroids were selected from the spheroid colony on the day of implantation.
Three days old white fertilized Leghorn chicken eggs (AA Lab Eggs, Inc, Westminster, CA, USA) were disinfected with 70% alcohol wipes, and incubated in a ventilated hatching incubator at 38°C for three hours. After incubation, eggs were removed from the incubator, and under light restricted conditions, egg contents were carefully transferred from the egg shells to a condiment cup. The cups are covered with a breathable polyethylene sheet (fisher brand) and returned to the incubator.
On day seven of embryonic stage (EA), the cups containing the chicken embryos were removed from the incubators. After a small incision was made on the outer membrane of the CAM, one tumor spheroid was implanted onto the mesoderm of CAM. Chicken embryos were returned to the incubator for 24 hrs. The implantation was assessed after 24 hours, and angiogenesis was assessed 7 days post implantation (EA 14) using a stereomicroscope (Olympus, model SZH) coupled to a digital camera (Olympus DP 10). After visual assessment, the CAM/spheroid interfaces were fixed with 10% formalin, removed from the CAM, and stored in 10% formalin solution overnight.
The samples were processed, embedded in paraffin and cut in 6 μm serial sections. The sections were stained with hematoxylin and eosin (H&E) to distinguish the tumor, tumor microvasculature and CAM environments.
RESULTS AND DISCUSSION
Microvasculature is observed around the spheroid region in Figure 1 (a). The middle H&E stained histological section of the CAM/tumor spheroid interface (largest cross-sectional area of tumor spheroid) shows three distinct microvessels at the center of the spheroid (Figure 1(b) ). New tumor regions are observed, as well as invasion in adjacent CAM areas.
Vascularized tumor spheroids were endogenously generated with this spheroid based shellless CAM model using spheroids derived from human glioblastoma (U-87 MG and ACBT), human breast cancer (MCF-7), and human pancreatic cancer (BXPC-3) cell lines. Endogenous tumor induced angiogenesis is evident by the penetration of the blood vessels to the center of the ACBT tumor spheroid as shown in Figure 1(b) . New tumor regions on the CAM (grey regions) adjacent to the tumor spheroid (middle purple mass) show the invasive capability of the tumor.
Not only is this system adaptable to different types of tumor cell lines to generate vascularized tumor spheroids, it can be used to investigate multiple tumor related processes including, tumor growth, angiogenesis, invasion and metastasis. The experimental configuration of this system allows its integration with biomedical engineering platforms for more sophisticated analysis of these biological processes.
The following section discusses applications of this model in some areas of biomedical research, including therapeutic, computational, and optical imaging studies.
APPLICATIONS IN BIOMEDICAL ENGINEERING RESEARCH

Application in Therapeutic Studies: Photodynamic Therapy
The CAM system has been used previously to study the effects of therapeutic drugs, such as chemotherapy drugs and photodynamic therapy (PDT) photosensitizers [19] on tumor cells and microvasculature. The advantage of using this CAM-spheroid model to study therapeutic efficacy is that, multiple spheroids can be implanted on the same system for dosimetry analysis and multi-parameter evaluations.
In a previous Photodynamic Therapy study, the shell-less CAM-tumor spheroid model was used to examine the effects of combined Amino-levulinic Acid (ALA) mediated PDT on tumor growth and microvasculature [9] . Damage to the tumor cells, extracellular matrix (ECM) and microvasculature (occluding) after acute ALA-mediated PDT was observed in Figure 2 (b). Individual blood cells are no longer distinct, and microvasculature lining was no longer visible (Figure 2(b) ), compared to normal tumor vasculature observed in Figure 2 (a). This shows that PDT was effective in causing vascular damage inside the tumor and on the CAM. The tumor cell shape and nucleus is no longer round. Previous studies have reported similar findings [19, 20] . Additionally, the extracellular matrix (ECM) of the tumor environment was observed to have a rough characteristic after PDT treatment.
Standard assays have used tumor cell suspensions embedded in the CAM to investigate the effect of PDT on tumor growth and angiogenesis [5] . Because cells suspensions tend to be more diffuse than spheroids, it is possible that in cell suspension, the PDT effect could be excessive since solid tumors do not appear in nature as cell suspensions. Furthermore, the use of exogenous angiogenic factors to induce angiogenesis may introduce differences in PDT efficacy. This in vivo shell-less CAM -tumor spheroid model would be a great model to conduct comparative studies since no exogenous factors are used to induce angiogenesis, and the morphology of the spheroid and its natural growth in the CAM represent a more realistic model of in vivo tumors.
The use of this model is not limited to photodynamic therapy. Nanotherapy has been a growing field of invest tigation in recent years. Scientists are interested in developing effective delivery mechanisms for therapeutic drugs of the same nanoscale as their biological targets. Scientists have used the traditional CAM system to test the delivery capabilities and target selectivity of therapeutic drugs and hydrophobic nanoparticles carrying therapeutic drugs [19] for photodynamic therapy based [21] and chemotherapy based [22] cancer treatments.
Nanoparticles for drug delivery and treatment purposes could be introduced into the CAM vascular network for analysis and validation of its effectiveness to reach the tumor spheroid region penetrate the tumor microvasculature and release the therapeutic drug. When used in conjunction with a color coded marker or visual tag, the nanoparticles can be tracked by means of in vivo imaging systems as they progress from the CAM vascular network to the tumor spheroid microvasculature. As discussed in the following section, Doppler studies [23, 24] , such as rate of nanoparticle delivery to the target site could also be quickly assessed by coupling our tumor system with a Doppler based imaging system.
Application in Optical Imaging Studies
Sophisticated imaging devices with cancer diagnostic implications can be validated and optimized using this fast and simple in vivo shell-less CAM -tumor spheroid model. The large aperture and flat surface of the model could facilitate imaging, system alignment and diagnostic experiments. This shell-less CAM tumor spheroid model was used to validate a combined Optical Coherence Tomography (OCT) and Optical Doppler tomography (ODT) system developed by Zhongping Chen et al [23, 25, 26] .
OCT has been used extensively in the clinical arena as an alternative to conventional systems such as MRI and CT to image the morphology of soft tissue [27] . In addition, ODT has been used to investigate and measure flow of blood and other fluids in tissue [24, 27, 28, 29, 30] . Both systems can be combined to provide both morphological and functional information of the tissue of interest [24, 28] .
The structure and morphology of the CAM-spheroid interface (Figure 3(a) and 3(c) ), as well as the blood flow in the vessels (Figures 3(b) and 3(c) ) were analyzed simultaneously using this combined system.
The morphology of CAM -tumor system was successfully assessed using this combined OCT-ODT system. The shape of the tumor spheroid as well as of the blood vessels along the surface of the CAM is clearly evident in Figures 3(a) and 3(c) . However, any branching of vessels into the tumor spheroid cannot be detected from the OCT and ODT images.
In addition, Figure 3(b) shows the real-time imaging of a functional major blood vessel in the CAM with large blood flow in the center, and less blood flow in the periphery. The ODT channel of the system can detect velocity changes based on color mapping, with black color representing zero velocity and red color representing maximum velocity. Thus, velocity increases from black, blue, and green, yellow to red. Figure 3(c) illustrates the variation of blood velocity along major vessels. Yellow regions depict centers of high velocity, while blue regions depict areas of low velocity. There is a blue region on the major blood vessel adjacent to the tumor spheroid. One can speculate that low blood flow in that region may be an indication of branching of vessels near the tumor causing a reduction of flow in main vessel. Further work is necessary to investigate this phenomena and any impact that tumor induced angiogenesis may have on blood flow in major vessels adjacent to tumor masses. Moreover, future advancements in the technology of the ODT system may allow the direction of blood flow to be detected, leading to the identification of different types of vessels in tissue such as capillaries and veins.
Application and Integration in In Silico and Computational Studies
Mathematical modeling and multi-scale computer simulations of tumor dynamics have a promising future as innovative diagnostic tools for treatment of cancer in addition and complementary to experimental and clinical investigations [31] .
Various mathematical models have been designed to perform in silico (on the computer) experiments or simulations to investigate and predict tumor behavior and response to therapy both in vivo and in vitro [32, 33] . These include modeling of tumor growth [34, 35, 36] , invasion [37] , angiogenesis and vascular growth [36, 38, 39, 40] , drug delivery [5, 41, 42] and therapeutic response [43, 44] . The in-silico results are compared with experimental and histological in vitro and in vivo data to validate and optimize the model's predictions. In addition to providing more insight into the cancer dynamics, the predictive capability of the computer tumor simulator may offer many future clinical applications.
To simulate tumor processes, these models require the acquisition of parameters such as tumor and necrotic core sizes before and after angiogenesis, density of blood vessels, speed of vessel migration towards the tumor, and gradients of growth factors involved in angiogenesis such as VEGF. The predictive capabilities of these models can be improved and optimized with the use of in vivo biological models that represent the dynamics of realistic tumors.
Current computational models often use tumor spheroids to integrate in vitro experimental data with vascular tumor growth simulations and vascular extrapolations [36, 39] . An example of in silico tumor spheroid inducing angiogenesis is shown in Figure 4 . The in vivo shell-less CAM 3-dimensional tumor spheroid model has the potential to enhance the capabilities of computational models by providing data for an in vivo and three-dimensional component representative of solid tumors. Thus, by integrating this data, tumor simulations will reflect more realistic representation of tumor vasculature and behavior.
The shell-less CAM tumor spheroid system may be used to acquire the parameters described above and validate computational models because it can yield fast results due to its short experimental period. Furthermore, the transparency of the CAM may facilitate data processing using imaging systems. In addition to the CAM's flat surface and closed system, the spheroid's initial symmetrical geometry may facilitate the formulation of equations and boundary conditions that represent the processes such as growth and angiogenesis that govern tumor proliferation. Thus, quantitative information can be extracted from tissue samples of the shell-less CAM tumor spheroid system. This model would be easily adaptable to existing mathematical models already using the tumor spheroid as an in vitro system, as the spheroid is simply being transferred to an in vivo platform (the CAM), enabling the incorporation of the in vivo component to existing mathematical principles.
Once these models are optimized they have the potential to be used to predict the aggressiveness of a patient's tumor. In addition, they could also predict a patient's tumor response prior to treatment.
That is, the in silico model could be used as a diagnostic tool to recommend the most effective individualized treatment based on the patient's prognosis. This can prevent the development of resistance to treatment by eliminating trial and error treatment sampling. Other advantages of the in silico model include providing fast and non-invasive diagnosis thus minimizing the discomfort to the patient, and improving overall quality of life. Finally, while the application of in-silico models in cancer therapy require improved understanding of cancer behavior and mechanisms, their versatility allows optimization and calibration of parameters to match with new developments and knowledge of cancer dynamics.
CONCLUSIONS
The in vivo 3-dimensional tumor spheroid based shell-less CAM model presented in this article is a new, attractive and practical system to study multiple mechanisms of tumor biology, including tumor growth, invasion, and angiogenesis. In addition, this system has a vast and dynamic application in many biomedical and bioengineering studies including drug discovery, nanoparticle delivery, therapeutic efficacy, cancer diagnostic imaging device development and validation, and mathematical and computer simulations of cancer dynamics [45] .
The development of this system successfully created vascularized spheroids in the CAM in the absence of exogenous factors four days after implantation. Due to the system's analogous representation of the microenvironment found in vivo solid tumors, this model can be used as an alternative or complement to animal models, and the research findings can provide preliminary implications to clinical studies. [36, 39] .
